Stockscreener 앱 받기
4.79
9.86%
0.43
시간 외 거래:
4.50
-0.29
-6.05%
Hcw Biologics Inc 주식(HCWB)의 최신 뉴스
Why HCW Biologics Inc. stock attracts strong analyst attentionFree Stock Market Insider Analysis - Newser
What makes HCW Biologics Inc. stock price move sharplyFree Join Group - Newser
How HCW Biologics Inc. stock performs during market volatilityTrend Following Trades - Newser
HCW Biologics (NASDAQ:HCWB) Stock Price Down 0.7% – What’s Next? - Defense World
Insiders Re-Evaluate Their US$3.05m Stock Purchase As HCW Biologics Falls To US$6.9m - Yahoo Finance
HCW Biologics announces full exercise of pre-funded warrants by Armistice Capital - Investing.com
HCW Biologics Completes Warrant Exercise with Armistice - TipRanks
HCW Biologics: Pioneering Multi-Specific T-Cell Engagers in the Fight Against Solid Tumors - AInvest
HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements - GlobeNewswire
HCW Biologics regains compliance with Nasdaq listing requirements - Investing.com
HCW Biologics Board Member Resignation and Director Elections - TipRanks
HCW Biologics (NASDAQ:HCWB) Rating Lowered to “Sell” at Wall Street Zen - Defense World
HCW Biologics Sees Strong Investor Interest in June - TipRanks
HCW Biologics Inc. (NASDAQ:HCWB) Short Interest Down 85.9% in May - Defense World
HCW Biologics (NASDAQ:HCWB) Trading Down 7.6% – Here’s What Happened - Defense World
Wall Street Zen Upgrades HCW Biologics (NASDAQ:HCWB) to “Hold” - Defense World
HCW Biologics Meets Nasdaq Listing Requirements in May 2025 - TipRanks
HCW Biologics partners with WY Biotech for immunotherapy By Investing.com - Investing.com South Africa
HCW Biologics Secures Licensing Agreement with WY Biotech - TipRanks
HCW Biologics partners with WY Biotech for immunotherapy - Investing.com Australia
HCW Biologics (HCWB) Secures $7M Upfront License Fee in New Agreement with WY Biotech | HCWB Stock News - GuruFocus
HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech - GlobeNewswire
HCW Biologics Engages Armistice in Securities Purchase - TipRanks
HCW Biologics (NASDAQ:HCWB) Price Target Lowered to $35.00 at Maxim Group - Defense World
HCW Biologics (HCWB) Price Target Adjusted by Maxim | HCWB Stock News - GuruFocus
HCWB: Maxim Group Maintains Buy Rating, Lowers Price Target | HC - GuruFocus
HCWB: Maxim Group Maintains Buy Rating, Lowers Price Target | HCWB Stock News - GuruFocus
HCW Biologics Issues Shares Through Warrant Exercise - TipRanks
Insider Buying: Hing Wong Acquires Additional Shares of HCW Biol - GuruFocus
HCW Biologics Enters Securities Purchase Agreement - TipRanks
HCW Biologics (NASDAQ:HCWB) Trading 9.1% Higher – Still a Buy? - Defense World
HCW Biologics Inc Reports Q1 2025 Earnings: Revenue at $5,065, Net Loss Reduced to $2.2 Million - GuruFocus
HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results - The Manila Times
HCW Biologics Inc. Reports Q1 2025 Financial Results and $5 Million Equity Offering Completion - Nasdaq
HCW Biologics Closes $5 Million Public Offering - TipRanks
HCW Biologics (HCWB) Launches $5M Follow-On Offering - GuruFocus
HCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules - The Manila Times
HCW Biologics Raises Fresh Capital: $5M Follow-On Offering Includes Attractive Warrant Package - Stock Titan
HCWB Announces Maxim Group LLC as Sole Placement Agent for Offer - GuruFocus
HCWB Announces Maxim Group LLC as Sole Placement Agent for Offering | HCWB Stock News - GuruFocus
Three layers of uncertainty - The Globe and Mail
Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales - Benzinga
Trading Halt for HCW Biologics (HCWB) Due to Volatility | HCWB S - GuruFocus
Trading Resumes for HCW Biologics (HCWB) | HCWB Stock News - GuruFocus
HCW Biologics Reports Positive Results For HCW9206 And Opens Commercial Partnership Talks - Nasdaq
HCW Biologics Says Studies Show HCW9206 Fusion Protein Addresses Key Challenges for CAR-T Therapies; Shares Surge - marketscreener.com
HCW Biologics (HCWB) Unveils Innovative Pathway for Enhanced CAR - GuruFocus
3.40%
2.49%
자본화:
|
볼륨(24시간):